The plenary session at the ASCO 2022 annual meeting saw that rarest of things at a scientific conference: a standing ovation.
Breast cancer treatment has changed dramatically over the past decade. One of the most important advances has been our growing ability to understand the biology of each patient’s cancer and use those insights to guide treatment decisions more precisely. That shift is helping make personalized cancer care a reality.
